Does This Star ‘GLO’? Taking Aim at Second-Line Diffuse Large B-Cell Lymphoma With Glofitamab Plus Gemcitabine and Oxaliplatin

/ The Hematologist

  • 2025-03-31 15:23:00リリースの日付
  • 20:16継続時間